TrialNature medicine2025

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial.

Scott Kopetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.